New spinout Healome Therapeutics to speed development for eye therapeutics
BHP founder-member the University of Birmingham has created a new spinout, Healome Therapeutics Ltd, to commercially deploy a platform that delivers a ‘pro-healing’ microenvironment for the leading…
Urine test for bladder cancer could replace thousands of invasive procedures each year
Birmingham researchers funded by Cancer Research UK and liquid biopsy company Nonacus have developed a new urine test for bladder cancer, which could reduce the need for invasive and time-consuming…
Civilians and military take part in study to improve concussion prognosis
A major UK study to identify new ways to accurately predict if patients will develop long-term complications as a consequence of concussion has been launched, led by experts at BHP founder-member t…
Genetically-determined levels of inflammation linked to neuropsychiatric illness
A potential link between inflammation and the structure of specific regions of the brain has been identified by researchers at BHP founder-members the University of Birmingham.
The study, publis…
Funding boost to help improve ovarian cancer survival rates
BHP’s newest member NHS Trust has been given a charity grant of £100,000 to help improve survival rates of women with ovarian cancer.
The Pan-Birmingham Gynaecological Cancer Centre, based at SW…
Continuation of funding secures Birmingham’s Clinical Research Facility
The Birmingham Health Partners NIHR Wellcome Trust Clinical Research Facility (CRF) has been successful in its renewal funding bid from the National Institute for Health Research.music
The NIHR …